by admin | Jul 6, 2021 | Clinicians, Participants, Researchers
Daily low-dose aspirin does not prevent cognitive decline in healthy older adults PRESS RELEASE: April 1, 2020 Researchers at Monash University and the Berman Center for Outcomes and Clinical Research in the US, have found that daily aspirin does not...
by admin | Jul 6, 2021 | Clinicians, Participants, Researchers
ASPREE-D sub-study finds daily aspirin not protective against late-life depression PRESS RELEASE: June 4, 2020 Taking low-dose aspirin daily does not prevent depression in healthy older adults, according to new findings from researchers from the ASPREE (ASPirin...
by admin | Jul 6, 2021 | Clinicians, Participants, Researchers
Statins may prevent heart attacks and strokes but may not prolong life free of disability PRESS RELEASE July 2, 2020 A new observational study shows the first-line cholesterol-lowering drugs known as statins are associated with fewer heart attacks and...
by admin | Dec 21, 2020 | Clinicians, Participants, Researchers
Professor Mike Ernst Michael E. Ernst is a clinical professor at the University of Iowa (UI) College of Pharmacy Department of Pharmacy Practice and Science. He is a pharmacist and a senior investigator to the ASPREE trial. Above: Prof Mike Ernst is a US based...
by admin | Sep 13, 2020 | Clinicians, Participants, Researchers
New analysis identifies potential risk of major GI bleeding in older adults A closer analysis of data from the ASPREE trial provides doctors, for the first time, with information about how much aspirin may increase the risk of gastrointestinal (GI) bleeding in...
Recent Comments